AlphAIAlphAI — Financial news for AI agents
investing.comOCT 52 min read$OPCH

Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R

Option Care Health (OPCH) shares rose 22% after hours on reports that McKesson and CD&R are in advanced talks to acquire it for over $5 billion, including debt. CD&R would hold 51%, McKesson 49%, with McKesson having future purchase rights. OPCH shares had fallen 27% year-to-date, with an enterprise value of $4.6 billion, including $1.2 billion in debt.

Original reporting
investing.com
Published Oct 5, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMergers & acquisitions
Primary signal
$OPCH
Bullish
high confidence
Mentioned
$OPCH · $MCK
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The reported acquisition talks introduce a significant premium to OPCH's valuation, prompting a sharp price move.

02

Market read

First‑report M&A news with a large valuation and immediate price reaction makes this a high‑impact trading event.

03

What to watch

Regulatory approval risk and integration challenges could dampen long‑term upside.

Relevance 9/10Novelty 9/10Timing: after‑hours today

Background

Option Care Health is the largest independent provider of medical infusion services in the U.S., serving over 315,000 patients.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Option Care Health shares jumped 22% after a Financial Times report that McKesson and CD&R are in advanced talks to acquire the company in a deal valued over $5 billion.

Expected impact

upward pressure as the market prices in the potential deal premium

Evidence & confidence

A disclosed $5 billion takeover talk for a mid‑cap healthcare provider is a material, first‑report event that caused a 22% after‑hours surge.

Market effects

Sector

Potential consolidation in the infusion services sector could spur M&A activity among peers.

Regional

U.S. healthcare stocks may see modest upside as the deal highlights valuation opportunities.

Global

Limited to U.S. healthcare; no broader macro impact.

Counterpoint

What could challenge this read

Deal may fall apart; the 22% rally could be overstated if negotiations stall.

Key entities

  • Company
    Option Care Health

    NASDAQ‑listed infusion services provider.

  • Company
    McKesson

    Healthcare distribution giant involved in the potential acquisition.

  • Private Equity
    Clayton Dubilier & Rice

    PE firm slated to take a controlling stake in the deal.

Read at source← All news

Also covered by

3 outlets

Related articles

OCT 7
$MCKHighAI 9/10

McKesson, private equity firm buy home infusion company, Option Care Health

McKesson Corporation and private equity firm Clayton Dubilier & Rice (CD&R) agreed to acquire Option Care Health, a home infusion company, for $5.8 billion. McKesson will invest $1.4 billion for a 49% stake, with CD&R taking 51%. The deal values Option Care Health at $32.05 per share, a 36% premium over Monday's closing price. Once completed, Option Care Health will become private and delist from Nasdaq.

managedhealthcareexecutive.com2 min
OCT 7
$LWHighAI 8/10

US Stock Movers: Lamb Weston, Option Care, Apogee Rally

Lamb Weston (LW) shares rose 11.85% after reporting Q1 sales of $1.67B and raising 2027 EBITDA guidance. Option Care (OPCH) jumped 32.8% on a $5.8B take-private deal. Apogee (APOG) gained 18.7% on strong Q2 earnings and raised FY2027 outlook. Constellation (CEG) surged 14.79% after a Google nuclear deal. RPM (RPM) rose 2.5% on record Q1 results.

hdfcsky.com2 min
OCT 7
$MCKHighAI 9/10

McKesson, CD&R to Buy Option Care for $5.8B

McKesson Corp. and private equity firm Clayton, Dubilier & Rice will acquire Option Care Health Inc. for $5.8 billion, or $32.05 per share, a 37% premium. McKesson will own 49%, with CD&R as the controlling shareholder. Option Care, a major provider of home and outpatient infusion care, will retain its management team. The deal aligns with McKesson's strategy to expand specialty care services, potentially increasing its ownership over time.

briefs.co2 min